nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active-specific immunization against melanoma: Is the problem at the receiving end?
|
Monsurrò, Vladia |
|
2003 |
|
6 |
p. 473-480 8 p. |
artikel |
2 |
Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine
|
Hsueh, Eddy C |
|
2003 |
|
6 |
p. 401-407 7 p. |
artikel |
3 |
Antigens in chronic lymphocytic leukemia—Implications for cell origin and leukemogenesis
|
Rosén, Anders |
|
2010 |
|
6 |
p. 400-409 10 p. |
artikel |
4 |
Anti-idiotypic monoclonal antibody cancer vaccines
|
Chapman, Paul B. |
|
1995 |
|
6 |
p. 367-374 8 p. |
artikel |
5 |
Augmenting the immunogenicity of carbohydrate tumor antigens
|
Livingston, Philip O. |
|
1995 |
|
6 |
p. 357-366 10 p. |
artikel |
6 |
Author index 1995
|
|
|
1995 |
|
6 |
p. I- 1 p. |
artikel |
7 |
Author Index and Keyword Index
|
|
|
2000 |
|
6 |
p. ix-xii nvt p. |
artikel |
8 |
Autophagy in cancer: Having your cake and eating it
|
Hoare, Matthew |
|
2011 |
|
6 |
p. 397-404 8 p. |
artikel |
9 |
Burkitt lymphoma
|
Klein, Eva |
|
2009 |
|
6 |
p. 345-346 2 p. |
artikel |
10 |
Burkitt lymphoma—A stalking horse for cancer research?
|
Klein, George |
|
2009 |
|
6 |
p. 347-350 4 p. |
artikel |
11 |
Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology
|
Rowe, Martin |
|
2009 |
|
6 |
p. 377-388 12 p. |
artikel |
12 |
Cancer, aging and the optimal tissue design
|
Komarova, Natalia L. |
|
2005 |
|
6 |
p. 494-505 12 p. |
artikel |
13 |
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells
|
Deaglio, Silvia |
|
2010 |
|
6 |
p. 416-423 8 p. |
artikel |
14 |
CD8+ T cell immunity to Epstein-Barr virus and Kaposi’s sarcoma-associated herpes virus
|
Hislop, Andrew D. |
|
2008 |
|
6 |
p. 416-422 7 p. |
artikel |
15 |
Cell transformation induced by Epstein–Barr virus—living dangerously
|
Rowe, Martin |
|
2001 |
|
6 |
p. 403-405 3 p. |
artikel |
16 |
Cellular senescence—A barrier against tumor development?
|
Larsson, Lars-Gunnar |
|
2011 |
|
6 |
p. 347-348 2 p. |
artikel |
17 |
Cellular senescence: A link between cancer and age-related degenerative disease?
|
Campisi, Judith |
|
2011 |
|
6 |
p. 354-359 6 p. |
artikel |
18 |
Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting
|
Burger, Jan A. |
|
2010 |
|
6 |
p. 424-430 7 p. |
artikel |
19 |
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma
|
Allen Chan, K.C |
|
2002 |
|
6 |
p. 489-496 8 p. |
artikel |
20 |
Clinical and biological significance of HLA-G expression in ovarian cancer
|
Sheu, Jim Jinn-Chyuan |
|
2007 |
|
6 |
p. 436-443 8 p. |
artikel |
21 |
CLL-like monoclonal B-cell lymphocytosis: Are we all bound to have it?
|
Scarfò, Lydia |
|
2010 |
|
6 |
p. 384-390 7 p. |
artikel |
22 |
Commentary
|
Klein, George |
|
2002 |
|
6 |
p. 415-418 4 p. |
artikel |
23 |
Contents and index of volume 7, 1996
|
|
|
1996 |
|
6 |
p. i-xv nvt p. |
artikel |
24 |
Contents of Volume 10
|
|
|
2000 |
|
6 |
p. i-viii nvt p. |
artikel |
25 |
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus
|
Delecluse, Henri-Jacques |
|
2008 |
|
6 |
p. 409-415 7 p. |
artikel |
26 |
Control of papillomavirus DNA replication and transcription
|
Desaintes, Christian |
|
1996 |
|
6 |
p. 339-347 9 p. |
artikel |
27 |
Current criteria to establish human carcinogens
|
Cogliano, Vincent James |
|
2004 |
|
6 |
p. 407-412 6 p. |
artikel |
28 |
Definition of tumor antigens suitable for vaccine construction
|
Lewis, Jonathan J. |
|
1995 |
|
6 |
p. 321-327 7 p. |
artikel |
29 |
Dendritic cells as vectors for immunotherapy of cancer
|
Paczesny, Sophie |
|
2003 |
|
6 |
p. 439-447 9 p. |
artikel |
30 |
Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration
|
Andersen, Mads Hald |
|
2003 |
|
6 |
p. 449-459 11 p. |
artikel |
31 |
Dynamics of colorectal cancer
|
Michor, Franziska |
|
2005 |
|
6 |
p. 484-493 10 p. |
artikel |
32 |
EBNA2 and Notch signalling in Epstein–Barr virus mediated immortalization of B lymphocytes
|
Zimber-Strobl, Ursula |
|
2001 |
|
6 |
p. 423-434 12 p. |
artikel |
33 |
EBV and genomic instability—A new look at the role of the virus in the pathogenesis of Burkitt's lymphoma
|
Gruhne, Bettina |
|
2009 |
|
6 |
p. 394-400 7 p. |
artikel |
34 |
Editorial Board
|
|
|
2008 |
|
6 |
p. CO2- 1 p. |
artikel |
35 |
Editorial Board
|
|
|
2007 |
|
6 |
p. CO2- 1 p. |
artikel |
36 |
Editorial Board
|
|
|
2009 |
|
6 |
p. CO2- 1 p. |
artikel |
37 |
Editorial Board
|
|
|
2010 |
|
6 |
p. CO2- 1 p. |
artikel |
38 |
Editorial Board
|
|
|
2011 |
|
6 |
p. CO2- 1 p. |
artikel |
39 |
Emergence and prevention of resistance against small molecule inhibitors
|
Wodarz, Dominik |
|
2005 |
|
6 |
p. 506-514 9 p. |
artikel |
40 |
Emerging concepts in tumor progression and therapy
|
Classon, Marie |
|
2000 |
|
6 |
p. 393-397 5 p. |
artikel |
41 |
Endemic Burkitt's lymphoma as a polymicrobial disease
|
Chene, Arnaud |
|
2009 |
|
6 |
p. 411-420 10 p. |
artikel |
42 |
Environmental and chemical carcinogenesis
|
Wogan, Gerald N. |
|
2004 |
|
6 |
p. 473-486 14 p. |
artikel |
43 |
Epidemiology of nasopharyngeal carcinoma
|
Yu, Mimi C. |
|
2002 |
|
6 |
p. 421-429 9 p. |
artikel |
44 |
Epigenetic alterations associated with cellular senescence: A barrier against tumorigenesis or a red carpet for cancer?
|
Decottignies, Anabelle |
|
2011 |
|
6 |
p. 360-366 7 p. |
artikel |
45 |
Epitope selection and development of peptide based vaccines to treat cancer
|
Celis, Esteban |
|
1995 |
|
6 |
p. 329-336 8 p. |
artikel |
46 |
Epstein–Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue
|
Bornkamm, Georg W. |
|
2009 |
|
6 |
p. 351-365 15 p. |
artikel |
47 |
Epstein–Barr virus complementary strand transcripts (CSTs / BARTs) and cancer
|
Smith, Paul |
|
2001 |
|
6 |
p. 469-476 8 p. |
artikel |
48 |
Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products
|
Ressing, Maaike E. |
|
2008 |
|
6 |
p. 397-408 12 p. |
artikel |
49 |
Epstein–Barr virus in the pathogenesis of NPC
|
Raab-Traub, Nancy |
|
2002 |
|
6 |
p. 431-441 11 p. |
artikel |
50 |
Estimation of mutation frequencies in normal mammalian cells and the development of cancer
|
Turker, Mitchell S. |
|
1998 |
|
6 |
p. 407-419 13 p. |
artikel |
51 |
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells
|
Speiser, Daniel E. |
|
2003 |
|
6 |
p. 461-472 12 p. |
artikel |
52 |
Evolution and the inevitability of human cancer
|
Simpson, Andrew J.G. |
|
1998 |
|
6 |
p. 439-445 7 p. |
artikel |
53 |
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses
|
Rouas-Freiss, Nathalie |
|
2007 |
|
6 |
p. 413-421 9 p. |
artikel |
54 |
Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer
|
Nakamura, Hajime |
|
2006 |
|
6 |
p. 444-451 8 p. |
artikel |
55 |
Failsafe program escape and EMT: A deleterious partnership
|
Ansieau, Stéphane |
|
2011 |
|
6 |
p. 392-396 5 p. |
artikel |
56 |
Familial nasopharyngeal carcinoma
|
Zeng, Yi-Xin |
|
2002 |
|
6 |
p. 443-450 8 p. |
artikel |
57 |
Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects
|
Prendergast, George C |
|
2000 |
|
6 |
p. 443-452 10 p. |
artikel |
58 |
Genetic alterations and DNA repair in human carcinogenesis
|
Dixon, Kathleen |
|
2004 |
|
6 |
p. 441-448 8 p. |
artikel |
59 |
Genetic and epigenetic changes in nasopharyngeal carcinoma
|
Lo, Kwok-Wai |
|
2002 |
|
6 |
p. 451-462 12 p. |
artikel |
60 |
Genetic instability in cancer: Theory and experiment
|
Beckman, Robert A. |
|
2005 |
|
6 |
p. 423-435 13 p. |
artikel |
61 |
Genetic variation and risk of chronic lymphocytic leukaemia
|
Crowther-Swanepoel, Dalemari |
|
2010 |
|
6 |
p. 363-369 7 p. |
artikel |
62 |
Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors
|
Blachere, Nathalie E. |
|
1995 |
|
6 |
p. 349-355 7 p. |
artikel |
63 |
Heterogeneity of papillomaviruses
|
Myers, Gerald |
|
1996 |
|
6 |
p. 349-358 10 p. |
artikel |
64 |
HLA control in the progression of human papillomavirus infections
|
Breitburd, Françoise |
|
1996 |
|
6 |
p. 359-371 13 p. |
artikel |
65 |
HLA-G and cancer
|
Carosella, Edgardo D. |
|
2007 |
|
6 |
p. 411-412 2 p. |
artikel |
66 |
HLA-G expression in malignant melanoma
|
Rebmann, Vera |
|
2007 |
|
6 |
p. 422-429 8 p. |
artikel |
67 |
HLA-G in B-chronic lymphocytic leukaemia: Clinical relevance and functional implications
|
Rebmann, Vera |
|
2007 |
|
6 |
p. 430-435 6 p. |
artikel |
68 |
HLA-G in the skin—Friend or foe?
|
Urosevic, Mirjana |
|
2007 |
|
6 |
p. 480-484 5 p. |
artikel |
69 |
How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
|
Allday, Martin J. |
|
2009 |
|
6 |
p. 366-376 11 p. |
artikel |
70 |
Human papillomaviruses in non-melanoma skin cancer
|
de Villiers, Ethel-Michele |
|
1999 |
|
6 |
p. 413-422 10 p. |
artikel |
71 |
Human papillomavirus life cycle: active and latent phases
|
Stubenrauch, Frank |
|
1999 |
|
6 |
p. 379-386 8 p. |
artikel |
72 |
Human papillomavirus vaccines
|
Breitburd, Françoise |
|
1999 |
|
6 |
p. 431-445 15 p. |
artikel |
73 |
Hypermutability and silent mutations in human carcinogenesis
|
Strauss, Bernard S. |
|
1998 |
|
6 |
p. 431-438 8 p. |
artikel |
74 |
Identification of EBV transforming genes by recombinant EBV technology
|
Izumi, Kenneth M. |
|
2001 |
|
6 |
p. 407-414 8 p. |
artikel |
75 |
Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
|
zur Hausen, Harald |
|
1999 |
|
6 |
p. 405-411 7 p. |
artikel |
76 |
Immune escape by Epstein–Barr virus associated malignancies
|
Münz, Christian |
|
2008 |
|
6 |
p. 381-387 7 p. |
artikel |
77 |
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis
|
Liang, Chengyu |
|
2008 |
|
6 |
p. 423-436 14 p. |
artikel |
78 |
Immune-refractory cancers and their little helpers—An extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
|
Wischhusen, Jörg |
|
2007 |
|
6 |
p. 459-468 10 p. |
artikel |
79 |
Immunotherapy of melanoma
|
Parmiani, Giorgio |
|
2003 |
|
6 |
p. 391-400 10 p. |
artikel |
80 |
Immunotherapy of melanoma: the good news, the bad ones and what to do next
|
Marincola, Francesco M. |
|
2003 |
|
6 |
p. 387-389 3 p. |
artikel |
81 |
Infectious agents and cancer: criteria for a causal relation
|
Pagano, Joseph S. |
|
2004 |
|
6 |
p. 453-471 19 p. |
artikel |
82 |
Inflammation as a tumor promoter in cancer induction
|
Philip, Mary |
|
2004 |
|
6 |
p. 433-439 7 p. |
artikel |
83 |
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015
|
McCormick, Frank |
|
2000 |
|
6 |
p. 453-459 7 p. |
artikel |
84 |
Interactions of the human papillomavirus E7 protein with cell cycle regulators
|
Jones, D.Leanne |
|
1996 |
|
6 |
p. 327-337 11 p. |
artikel |
85 |
Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation
|
Zhang, Luwen |
|
2001 |
|
6 |
p. 445-453 9 p. |
artikel |
86 |
Introduction
|
Simpson, Andrew J.G. |
|
1998 |
|
6 |
p. 403-405 3 p. |
artikel |
87 |
Introduction
|
de Villiers, Ethel-Michele |
|
1999 |
|
6 |
p. 377- 1 p. |
artikel |
88 |
Introduction: Cancer vaccines
|
Livingston, Philip O. |
|
1995 |
|
6 |
p. 319-320 2 p. |
artikel |
89 |
Introduction: Human papillomavirus
|
Thierry, Françoise |
|
1996 |
|
6 |
p. 307- 1 p. |
artikel |
90 |
Introduction: nasopharyngeal cancer
|
Huang, Dolly P |
|
2002 |
|
6 |
p. 419- 1 p. |
artikel |
91 |
LMP1 structure and signal transduction
|
Eliopoulos, Aristides G |
|
2001 |
|
6 |
p. 435-444 10 p. |
artikel |
92 |
Local delivery of poxvirus vaccines for melanoma
|
Hörig, Heidi |
|
2003 |
|
6 |
p. 417-422 6 p. |
artikel |
93 |
Manipulation of the immune response by Epstein–Barr virus and Kaposi's sarcoma-associated herpesvirus: Consequences for tumor development
|
Ressing, Maaike E. |
|
2008 |
|
6 |
p. 379-380 2 p. |
artikel |
94 |
Matrix metalloproteinases in tumor invasion and metastasis
|
Stamenkovic, Ivan |
|
2000 |
|
6 |
p. 415-433 19 p. |
artikel |
95 |
Mechanism of HPV E6 proteins in cellular transformation
|
Huibregtse, Jon M. |
|
1996 |
|
6 |
p. 317-326 10 p. |
artikel |
96 |
MicroRNAs of Kaposi's sarcoma-associated herpes virus
|
Ganem, Don |
|
2008 |
|
6 |
p. 437-440 4 p. |
artikel |
97 |
Modern criteria to determine the etiology of human carcinogens
|
Mossman, Brooke T. |
|
2004 |
|
6 |
p. 449-452 4 p. |
artikel |
98 |
Modern criteria to establish human cancer etiology
|
Carbone, Michele |
|
2004 |
|
6 |
p. 397-398 2 p. |
artikel |
99 |
Molecular basis of CLL
|
Pekarsky, Yuri |
|
2010 |
|
6 |
p. 370-376 7 p. |
artikel |
100 |
Motexafin gadolinium: A novel redox active drug for cancer therapy
|
Magda, Darren |
|
2006 |
|
6 |
p. 466-476 11 p. |
artikel |
101 |
Multiple roles of LMP1 in Epstein-Barr virus induced immune escape
|
Middeldorp, J.M. |
|
2008 |
|
6 |
p. 388-396 9 p. |
artikel |
102 |
Multistep and multifactorial carcinogenesis: when does a contributing factor become a carcinogen?
|
Carbone, Michele |
|
2004 |
|
6 |
p. 399-405 7 p. |
artikel |
103 |
Multistep skin cancer in mice as a model to study the evolution of cancer cells
|
Kemp, Christopher J. |
|
2005 |
|
6 |
p. 460-473 14 p. |
artikel |
104 |
Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy
|
Lee, Steven P |
|
2002 |
|
6 |
p. 463-471 9 p. |
artikel |
105 |
Natural selection in neoplastic progression of Barrett's esophagus
|
Maley, Carlo C. |
|
2005 |
|
6 |
p. 474-483 10 p. |
artikel |
106 |
New aspects of integrin signaling in cancer
|
Parise, Leslie V |
|
2000 |
|
6 |
p. 407-414 8 p. |
artikel |
107 |
New insights into the pathogenesis of chronic lymphocytic leukemia
|
Klein, Ulf |
|
2010 |
|
6 |
p. 377-383 7 p. |
artikel |
108 |
[No title]
|
Wodarz, D. |
|
2005 |
|
6 |
p. 421-422 2 p. |
artikel |
109 |
Novel gene therapy approach for nasopharyngeal carcinoma
|
Liu, Fei-Fei |
|
2002 |
|
6 |
p. 505-515 11 p. |
artikel |
110 |
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
|
Larsson, Lars-Gunnar |
|
2011 |
|
6 |
p. 367-376 10 p. |
artikel |
111 |
On the origin of multiple mutations in human cancers
|
Jackson, Aimee L. |
|
1998 |
|
6 |
p. 421-429 9 p. |
artikel |
112 |
On the potential of thioredoxin reductase inhibitors for cancer therapy
|
Urig, Sabine |
|
2006 |
|
6 |
p. 452-465 14 p. |
artikel |
113 |
Papillomaviruses in non-melanoma skin cancer: epidemiological aspects
|
Kiviat, Nancy B. |
|
1999 |
|
6 |
p. 397-403 7 p. |
artikel |
114 |
Papillomavirus-like particles and HPV vaccine development
|
Schiller, John T. |
|
1996 |
|
6 |
p. 373-382 10 p. |
artikel |
115 |
Peptide vaccine trials for melanoma: preclinical background and clinical results
|
Talebi, Tony |
|
2003 |
|
6 |
p. 431-438 8 p. |
artikel |
116 |
Proof for EBV's sustaining role in Burkitt's lymphomas
|
Vereide, David |
|
2009 |
|
6 |
p. 389-393 5 p. |
artikel |
117 |
Rational peptide-based tumour vaccine development and T cell monitoring
|
Scheibenbogen, Carmen |
|
2003 |
|
6 |
p. 423-429 7 p. |
artikel |
118 |
Restricted expression of EBV encoded proteins in in vitro infected CLL cells
|
Klein, Eva |
|
2010 |
|
6 |
p. 410-415 6 p. |
artikel |
119 |
Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
|
Sondak, Vernon K |
|
2003 |
|
6 |
p. 409-415 7 p. |
artikel |
120 |
Role and limitations of epidemiology in establishing a causal association
|
Franco, Eduardo L. |
|
2004 |
|
6 |
p. 413-426 14 p. |
artikel |
121 |
Role of EBV in microRNA dysregulation in Burkitt lymphoma
|
De Falco, Giulia |
|
2009 |
|
6 |
p. 401-406 6 p. |
artikel |
122 |
Role of LMP1 in immune control of EBV infection
|
Pai, Saparna |
|
2001 |
|
6 |
p. 455-460 6 p. |
artikel |
123 |
Role of telomeres and telomerase in cancer
|
Shay, Jerry W. |
|
2011 |
|
6 |
p. 349-353 5 p. |
artikel |
124 |
Selection of potent immunological adjuvants for vaccine construction
|
McElrath, Margaret Juliana |
|
1995 |
|
6 |
p. 375-385 11 p. |
artikel |
125 |
Selective evolutionary pressure from the tissue microenvironment drives tumor progression
|
Smalley, Keiran S.M. |
|
2005 |
|
6 |
p. 451-459 9 p. |
artikel |
126 |
Senescence and pre-malignancy: How do tumors progress?
|
Saab, Raya |
|
2011 |
|
6 |
p. 385-391 7 p. |
artikel |
127 |
Signalling events regulating lymphoid growth and survival
|
Brennan, Paul |
|
2001 |
|
6 |
p. 415-421 7 p. |
artikel |
128 |
Soluble HLA-G: Are they clinically relevant?
|
Pistoia, Vito |
|
2007 |
|
6 |
p. 469-479 11 p. |
artikel |
129 |
Somatic evolution of cancer cells
|
Boland, C. Richard |
|
2005 |
|
6 |
p. 436-450 15 p. |
artikel |
130 |
Structure, expression and function of HLA-G in renal cell carcinoma
|
Seliger, Barbara |
|
2007 |
|
6 |
p. 444-450 7 p. |
artikel |
131 |
Subject index 1995
|
|
|
1995 |
|
6 |
p. III-VIII nvt p. |
artikel |
132 |
Targeting tumor vasculature with homing peptides from phage display
|
Ruoslahti, Erkki |
|
2000 |
|
6 |
p. 435-442 8 p. |
artikel |
133 |
T-cell function in chronic lymphocytic leukaemia
|
Riches, John C. |
|
2010 |
|
6 |
p. 431-438 8 p. |
artikel |
134 |
Telomerase and human tumorigenesis
|
Stewart, Sheila A. |
|
2000 |
|
6 |
p. 399-406 8 p. |
artikel |
135 |
The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia
|
Galloway, Denise A. |
|
1996 |
|
6 |
p. 309-315 7 p. |
artikel |
136 |
The epigenetics of cancer etiology
|
Feinberg, Andrew P. |
|
2004 |
|
6 |
p. 427-432 6 p. |
artikel |
137 |
The interaction between p53 and papillomaviruses
|
Mantovani, Fiamma |
|
1999 |
|
6 |
p. 387-395 9 p. |
artikel |
138 |
The Myc/macrophage tango: Oncogene-induced senescence, Myc style
|
Lee, Soyoung |
|
2011 |
|
6 |
p. 377-384 8 p. |
artikel |
139 |
The next wave of recombinant and synthetic anticancer vaccines
|
Irvine, Kari R. |
|
1995 |
|
6 |
p. 337-347 11 p. |
artikel |
140 |
The role of EBERs in oncogenesis
|
Takada, Kenzo |
|
2001 |
|
6 |
p. 461-467 7 p. |
artikel |
141 |
The role of HLA-G in gastrointestinal inflammatory disease and malignancy
|
Downs-Kelly, Erinn |
|
2007 |
|
6 |
p. 451-458 8 p. |
artikel |
142 |
The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia
|
Packham, Graham |
|
2010 |
|
6 |
p. 391-399 9 p. |
artikel |
143 |
The serological response to papillomaviruses
|
Dillner, Joakim |
|
1999 |
|
6 |
p. 423-430 8 p. |
artikel |
144 |
The significance of LMP1 expression in nasopharyngeal carcinoma
|
Tsao, Sai Wah |
|
2002 |
|
6 |
p. 473-487 15 p. |
artikel |
145 |
The thioredoxin system in cancer
|
Arnér, Elias S.J. |
|
2006 |
|
6 |
p. 420-426 7 p. |
artikel |
146 |
The thioredoxin system in cancer—introduction to a thematic volume of Seminars in Cancer Biology
|
Arnér, Elias S.J. |
|
2006 |
|
6 |
p. 419- 1 p. |
artikel |
147 |
The use of genetic instability as a clinical tool for cancer diagnosis
|
Bevilacqua, Roberta A.U. |
|
1998 |
|
6 |
p. 447-453 7 p. |
artikel |
148 |
Thioredoxin and protein kinases in redox signaling
|
Fujino, Go |
|
2006 |
|
6 |
p. 427-435 9 p. |
artikel |
149 |
Thioredoxin in cancer—Role of histone deacetylase inhibitors
|
Marks, Paul A. |
|
2006 |
|
6 |
p. 436-443 8 p. |
artikel |
150 |
To the genesis of Burkitt lymphoma: Regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes
|
Nagy, Noemi |
|
2009 |
|
6 |
p. 407-410 4 p. |
artikel |
151 |
Treatment strategy and clinical experience
|
Teo, Peter M.L |
|
2002 |
|
6 |
p. 497-504 8 p. |
artikel |
152 |
Viral and cellular MARCH ubiquitin ligases and cancer
|
Wang, Xiaoli |
|
2008 |
|
6 |
p. 441-450 10 p. |
artikel |
153 |
Volume and contents of volume 8, 1998
|
|
|
1998 |
|
6 |
p. i-xv nvt p. |
artikel |
154 |
Volume Contents and Index
|
|
|
1999 |
|
6 |
p. i-xii nvt p. |
artikel |
155 |
Volume contents, Auhtor and Keywords
|
|
|
2002 |
|
6 |
p. I-X nvt p. |
artikel |
156 |
Volume Contents, Author and Keyword Indexes
|
|
|
2003 |
|
6 |
p. I-XI nvt p. |
artikel |
157 |
Where is the biology of CLL leading us?
|
Caligaris-Cappio, Federico |
|
2010 |
|
6 |
p. 361-362 2 p. |
artikel |